Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meglumine antimoniate with miltefosine vs meglumine antimoniate alone in cutaneous leishmaniasis
TCTR20260319004Phase 1Completed
- Sponsor
- Combined Military Hospital Quetta
- Start
- Jul 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of meglumine antimoniate and miltefosine in cutaneous leishmaniasis (CL) (2 arms), sponsored by Combined Military Hospital Quetta. Started Jul 2025; status: completed.
02
Drugs
meglumine antimoniatemiltefosine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on TCTR20260319004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260319004.